BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17006909)

  • 21. Fibrogenic/Angiogenic Linker for Non-Invasive Assessment of Hepatic Fibrosis Staging in Chronic Hepatitis C Among Egyptian Patients.
    Toson EA; Shiha GE; Abdelgaleel AE
    Ann Hepatol; 2017 November-December,; 16(6):862-873. PubMed ID: 29055924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients.
    Omran MM; Farid K; Emran TM; Attallah AA
    Arab J Gastroenterol; 2011 Jun; 12(2):74-9. PubMed ID: 21684477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical, virological, and pathological significance of hepatic bile duct injuries in Chinese patients with chronic hepatitis C.
    Hwang SJ; Luo JC; Chu CW; Lai CR; Tsay SH; Chang FY; Lee SD
    J Gastroenterol; 2001 Jun; 36(6):392-8. PubMed ID: 11428585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Racial differences in the progression to cirrhosis and hepatocellular carcinoma in HCV-infected veterans.
    El-Serag HB; Kramer J; Duan Z; Kanwal F
    Am J Gastroenterol; 2014 Sep; 109(9):1427-35. PubMed ID: 25070058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and Pathological Risk Factors Associated with Liver Fibrosis and Steatosis in African-Americans with Chronic Hepatitis C.
    Afsari A; Lee E; Shokrani B; Boortalary T; Sherif ZA; Nouraie M; Laiyemo AO; Alkhalloufi K; Brim H; Ashktorab H
    Dig Dis Sci; 2017 Aug; 62(8):2159-2165. PubMed ID: 28612194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathological features and genotype distribution in patients with hepatitis C virus chronic liver disease.
    Abraham R; Ramakrishna B; Balekuduru A; Daniel HD; Abraham P; Eapen CE; Kurian G
    Indian J Gastroenterol; 2009; 28(2):53-8. PubMed ID: 19696989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients.
    Wang CC; Liu CH; Lin CL; Wang PC; Tseng TC; Lin HH; Kao JH
    J Formos Med Assoc; 2015 Oct; 114(10):923-8. PubMed ID: 26279173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.
    Barreiro P; Martín-Carbonero L; Núñez M; Rivas P; Morente A; Simarro N; Labarga P; González-Lahoz J; Soriano V
    Clin Infect Dis; 2006 Apr; 42(7):1032-9. PubMed ID: 16511772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers.
    Islam S; Antonsson L; Westin J; Lagging M
    Scand J Gastroenterol; 2005 Jul; 40(7):867-72. PubMed ID: 16109665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simple non-invasive markers as a predictor of fibrosis and viral response in chronic hepatitis C patients.
    Arabul M; Aslan F; Alper E; Akpinar Z; Çelık M; Kandemır A; Vatansever S; Ünsal B
    Turk J Gastroenterol; 2012; 23(5):538-45. PubMed ID: 23161299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index.
    Sud A; Hui JM; Farrell GC; Bandara P; Kench JG; Fung C; Lin R; Samarasinghe D; Liddle C; McCaughan GW; George J
    Hepatology; 2004 May; 39(5):1239-47. PubMed ID: 15122752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.
    Martin-Carbonero L; de Ledinghen V; Moreno A; Maida I; Foucher J; Barreiro P; Romero M; Satta G; Garcia-Samaniego J; Gonzalez-Lahoz J; Soriano V
    J Viral Hepat; 2009 Nov; 16(11):790-5. PubMed ID: 19413693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-invasive assessment of liver steatosis and fibrosis in HIV/HCV- and HCV- infected patients.
    Li Vecchi V; Giannitrapani L; Di Carlo P; Mazzola G; Colletti P; La Spada E; Vizzini G; Montalto G; Soresi M
    Ann Hepatol; 2013; 12(5):740-8. PubMed ID: 24018492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aspartate aminotransferase to platelet ratio index - a reliable predictor of therapeutic efficacy and improvement of Ishak score in chronic hepatitis B patients treated with nucleoside analogues.
    Peng J; Cai S; Yu T; Chen Y; Zhu Y; Sun J
    Scand J Clin Lab Invest; 2016; 76(2):133-42. PubMed ID: 26878877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association of IL28B genotype with the histological features of chronic hepatitis C is HCV genotype dependent.
    D'Ambrosio R; Aghemo A; De Francesco R; Rumi MG; Galmozzi E; De Nicola S; Cheroni C; Clark PJ; Ronchi G; Lampertico P; Colombo M
    Int J Mol Sci; 2014 Apr; 15(5):7213-24. PubMed ID: 24776764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients.
    Karagoz E; Ulcay A; Tanoglu A; Kara M; Turhan V; Erdem H; Oncul O; Gorenek L
    Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1320-4. PubMed ID: 25210777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transient elastography compared to liver biopsy and morphometry for predicting fibrosis in pediatric chronic liver disease: Does etiology matter?
    Behairy Bel-S; Sira MM; Zalata KR; Salama el-SE; Abd-Allah MA
    World J Gastroenterol; 2016 Apr; 22(16):4238-49. PubMed ID: 27122674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation and comparison of simple noninvasive models for the prediction of liver fibrosis in chronic hepatitis C.
    Amorim TG; Staub GJ; Lazzarotto C; Silva AP; Manes J; Ferronato Mda G; Shiozawa MB; Narciso-Schiavon JL; Dantas-Correa EB; Schiavon Lde L
    Ann Hepatol; 2012; 11(6):855-61. PubMed ID: 23109448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors associated with the progression of fibrosis on liver biopsy in Alaska Native and American Indian persons with chronic hepatitis C.
    Livingston SE; Deubner H; Bruden DL; McMahon BJ; Homan CE; Townshend-Bulson LJ; Bruce MG; Hennessy TW; Williams JL; Gretch DR
    Can J Gastroenterol; 2010 Jul; 24(7):445-51. PubMed ID: 20652161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C infection at a tertiary hospital in South Africa: Clinical presentation, non-invasive assessment of liver fibrosis, and response to therapy.
    Abuelhassan WB; Gasim GI; Ally R; Menezes C
    S Afr Med J; 2020 Aug; 110(9):920-925. PubMed ID: 32880279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.